Literature DB >> 7592567

Uroporphyrinogen decarboxylase.

G H Elder1, A G Roberts.   

Abstract

Uroporphyrinogen decarboxylase (EC 4.1.1.37) catalyzes the decarboxylation of uroporphyrinogen III to coproporphyrinogen III. The amino acid sequences, kinetic properties, and physicochemical characteristics of enzymes from different sources (mammals, yeast, bacteria) are similar, but little is known about the structure/function relationships of uroporphyrinogen decarboxylases. Halogenated and other aromatic hydrocarbons cause hepatic uroporphyria by decreasing hepatic uroporphyrinogen decarboxylase activity. Two related human porphyrias, porphyria cutanea tarda and hepatoerythropoietic porphyria, also result from deficiency of this enzyme. The roles of inherited and acquired factors, including iron, in the pathogenesis of human and experimental uroporphyrias are reviewed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592567     DOI: 10.1007/BF02110035

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  73 in total

1.  Porphyria cutanea tarda and HLA-linked hemochromatosis--all in the family?

Authors:  P C Adams; L W Powell
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

2.  Investigations on the presence of porphyrinogen carboxy-lyase inhibitor in the liver of rats intoxicated with hexachlorobenzene.

Authors:  M C Rios de Molina; R Wainstok de Calmanovici; L C San Martin de Viale
Journal:  Int J Biochem       Date:  1980

3.  Evidence for cytochrome P450-mediated oxidation of uroporphyrinogen by cell-free liver extracts from chick embryos treated with 3-methylcholanthrene.

Authors:  P Sinclair; R Lambrecht; J Sinclair
Journal:  Biochem Biophys Res Commun       Date:  1987-08-14       Impact factor: 3.575

4.  Is hepatitis C virus infection a trigger of porphyria cutanea tarda?

Authors:  C Herrero; A Vicente; M Bruguera; M G Ercilla; J M Barrera; J Vidal; J Terés; J M Mascaró; J Rodés
Journal:  Lancet       Date:  1993-03-27       Impact factor: 79.321

5.  Uroporphyria produced in mice by 20-methylcholanthrene and 5-aminolaevulinic acid.

Authors:  A J Urquhart; G H Elder; A G Roberts; R W Lambrecht; P R Sinclair; W J Bement; N Gorman; J A Sinclair
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

6.  Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase.

Authors:  J G Straka; J P Kushner
Journal:  Biochemistry       Date:  1983-09-27       Impact factor: 3.162

7.  Purification of uroporphyrinogen decarboxylase from human erythrocytes. Immunochemical evidence for a single protein with decarboxylase activity in human erythrocytes and liver.

Authors:  G H Elder; J A Tovey; D M Sheppard
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

8.  Cloning and characterization of the Bacillus subtilis hemEHY gene cluster, which encodes protoheme IX biosynthetic enzymes.

Authors:  M Hansson; L Hederstedt
Journal:  J Bacteriol       Date:  1992-12       Impact factor: 3.490

9.  Oxidation of uroporphyrinogen by methylcholanthrene-induced cytochrome P-450. Essential role of cytochrome P-450d.

Authors:  J M Jacobs; P R Sinclair; W J Bement; R W Lambrecht; J F Sinclair; J A Goldstein
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

10.  Oxidation of uroporphyrinogens by hydroxyl radicals. Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase.

Authors:  J E Francis; A G Smith
Journal:  FEBS Lett       Date:  1988-06-20       Impact factor: 4.124

View more
  14 in total

1.  Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda.

Authors:  L Christiansen; A Bygum; A Jensen; K Thomsen; F Brandrup; M Hørder; N E Petersen
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

Review 2.  Porphyrias at a glance: diagnosis and treatment.

Authors:  Maria Domenica Cappellini; Valentina Brancaleoni; Giovanna Graziadei; Dario Tavazzi; Elena Di Pierro
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

Review 3.  Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors.

Authors:  Dulmini P Barupala; Stephen P Dzul; Pamela Jo Riggs-Gelasco; Timothy L Stemmler
Journal:  Arch Biochem Biophys       Date:  2016-01-16       Impact factor: 4.013

4.  Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.

Authors:  P R Sinclair; N Gorman; T Dalton; H S Walton; W J Bement; J F Sinclair; A G Smith; D W Nebert
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

Review 5.  Hepatic porphyrias in children.

Authors:  G H Elder
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 6.  [Hepatic porphyrias and alcohol].

Authors:  M O Doss; A Kühnel; U Gross; I Sieg
Journal:  Med Klin (Munich)       Date:  1999-06-15

Review 7.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

Review 8.  Erythropoietic and hepatic porphyrias.

Authors:  U Gross; G F Hoffmann; M O Doss
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

9.  Crystal structure of uroporphyrinogen decarboxylase from Bacillus subtilis.

Authors:  Jun Fan; Qun Liu; Quan Hao; Maikun Teng; Liwen Niu
Journal:  J Bacteriol       Date:  2006-11-22       Impact factor: 3.490

10.  A porphyrin pathway impairment is responsible for the phenotype of a dominant disease lesion mimic mutant of maize.

Authors:  G Hu; N Yalpani; S P Briggs; G S Johal
Journal:  Plant Cell       Date:  1998-07       Impact factor: 11.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.